Safety and Efficacy of Intracameral Zimoxin for Prevention of Endophthalmitis After Cataract Surgery

Starting soon · Phase 2/Phase 3 · Has a placebo group

Conditions studied: Endophthalmitis

In brief

Intracameral injection of 0.1% moxifloxacin solution after cataract surgery to prevent endophthalmitis

Key facts

Study ID

NCT03244072

Run by

Jason Ahee, M.D.

People needed

60000

Starts

2026-06-01

Expected to finish

2031-10-01

Last updated by the study team

2025-09-25

Who can join

Age: 40 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• visually significant cataracts

You may not qualify if…

• allergy to fluoroquinolones, cobalamin (B12)

Where it is running

• Zion Eye Institute — St. George, Utah, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.